Home
Categories
Pharmaceutical
Hi Tech Manufacturing
Food
Finance
Design & Build
Containment
Cleaning
Sustainability
HVAC
Personal Protection
Regulatory
CT CONFERENCE
Company News
Events
Directory
Search
Close search
Home
Company
Samsung Biologics
Samsung Biologics
Activities:
Pharmaceutical
X
LinkedIn
Trending Articles
Mewar Polytex launches non-woven disposable protective wear line
Mewar Polytex has launched its Dispowear line of non-woven disposable protective wear for hospitals, pharmaceuticals, chemicals, food processing, and cleanroom environments
Pfizer wins 2024 ISPE FOYA award with "central pool concept" API facility design
Pfizer has won the Operations, Project Execution category at 2024's ISPE Facility of the Year Awards. Purtias Asgard completed work as the cleanroom subcontractor for this...
TSMC comments on cleanroom evacuation
Cleanroom Technology reached out to TSMC to see how the recent magnitude 4 earthquakes had impacted semiconductor production operations
Envair and Total Containment Solutions re-brand to become Envair Technology
Envair and TCS are now operating under one logo and name, Envair Technology
Identifying and preventing contaminant leakage from your cleanroom
A common solution to machinery contamination in a cleanroom is to build a cleanroom within a cleanroom using partitions or curtains, to isolate the machine. Chris Lindlar from...
Upcoming event
Clinical Pharmacy Congress
10-11 May 2024 | Conference | London, UK
See all
Related Content
Pharmaceutical
Samsung Biologics selects company to automate microbiology QC testing
Samsung Biologics has selected Rapid Micro Biosystems’ Growth Direct platform to automate critical microbiology quality control testing
Sustainability
CDMO Samsung Biologics receives Terra Carta Seal for sustainable operations
The South Korean pharmaceutical CDMO has built an environmental management strategy that includes process optimisation, renewable energy transition, and minimising the use of single-use products
Pharmaceutical
Samsung Biologics appoints industry veteran as CEO
Samsung Biologics has announced John Rim as its President and CEO
Finance
Samsung Biologics plans $2bn 'Super Plant' for biomanufacturing
The company has also said that it is in negotiations with the authorities at Incheon Free Economic Zone to purchase additional land for its second bio complex
Pharmaceutical
Samsung BioLogics Plant 3 starts cGMP production
Facility in Incheon, South Korea, features 180,000L capacity, 20% more than its sister plant. The site passed validation in 10 months
Subscribe now